Hatae, R., Chamoto, K., Kim, Y
Doses of 5 to 10 nmol/kg/day were administered via subcutaneous injection just before the start of the dark cycle
Growth hormone plays a direct role in protein synthesis and musclefiber maintenance, which is why clinicians are evaluating whether sermorelin, agrowth hormone-releasing peptide, may support better body composition outcomeswhen used alongside GLP-1 medications
Patients should contact their GP if they experience significant deterioration in blood glucose control (persistent readings above 15 mmol/L, symptoms of hyperglycaemia such as excessive thirst or urination), unexplained weight changes, or any concerning symptoms after stopping treatment
Blood sugar control may become less effective, and the benefits of weight loss may be reduced